Dashboard
Manage Tickers

DRIODarioHealth Corp.

Nasdaq mydario.com


$ 1.49 $ 0.01 (0.68 %)    

Friday, 26-Apr-2024 15:50:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 1.48
$ 1.49
$ 0.00 x 0
$ 0.00 x 0
$ 1.48 - $ 1.50
$ 0.68 - $ 4.58
73,065
na
41.99M
$ 1.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-09-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-21-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-09-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-12-2020 06-30-2020 10-Q
16 05-12-2020 03-31-2020 10-Q
17 03-17-2020 12-31-2019 10-K
18 10-28-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-13-2019 03-31-2019 10-Q
21 03-25-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-19-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 03-22-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 05-11-2016 03-31-2016 10-Q
33 02-08-2016 12-31-2015 10-K
34 11-13-2015 09-30-2015 10-Q
35 08-12-2015 06-30-2015 10-Q
36 05-14-2015 03-31-2015 10-Q
37 03-24-2015 12-31-2014 10-K
38 11-14-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-14-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

dario-publishes-new-peer-reviewed-study-that-deepens-the-body-of-evidence-that-managing-cardiometabolic-conditions-in-one-integrated-platform-improves-clinical-outcomes
Dario Publishes New Peer-Reviewed Study Th...
04/25/2024 12:47:01

Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solution for members to manage ...

dario-signs-two-employers-for-cardiometabolic-suite-with-integrated-glp-1-solution-beginning-in-q2-of-2024
Dario Signs Two Employers For Cardiometabo...
04/18/2024 12:34:17

Dario selected to provide integrated and proven solutions to improve employee cardiometabolic healthNEW YORK, April 18, 2024 /P...

dario-publishes-two-peer-reviewed-studies-demonstrating-impact-of-digital-behavioral-health
Dario Publishes Two Peer-Reviewed Studies ...
04/10/2024 12:34:41

Studies include a Randomized Controlled Trial demonstrating significant reduction in perceived stress for teens

two-national-employers-select-darios-integrated-chronic-condition-solution-to-improve-employee-health
Two National Employers Select Dario's Inte...
04/02/2024 12:40:18

DarioHealth Corp. (NASDAQ:DRIO) ("Dario" or the "Company"), a leader in the global digital health market, annou...

stifel-maintains-buy-on-dariohealth-maintains-4-price-target
Stifel Maintains Buy on DarioHealth, Maint...
04/01/2024 15:01:39

Stifel analyst David Grossman maintains DarioHealth (NASDAQ:DRIO) with a Buy and maintains $4 price target.

dariohealth-q4-eps-041-beats-054-estimate
DarioHealth Q4 EPS $(0.41) Beats $(0.54) E...
03/28/2024 10:43:02

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.54) b...

dariohealth-q4-sales-362m-beat-357m-estimate
DarioHealth Q4 Sales $3.62M Beat $3.57M Es...
03/28/2024 10:35:24

DarioHealth (NASDAQ:DRIO) reported quarterly sales of $3.62 million which beat the analyst consensus estimate of $3.57 million ...

earnings-scheduled-for-march-28-2024
Earnings Scheduled For March 28, 2024
03/28/2024 09:24:44

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

earnings-outlook-for-dariohealth
Earnings Outlook For DarioHealth
03/27/2024 17:00:55

new-research-from-dario-demonstrates-ability-to-deliver-improved-health-outcomes-with-integrated-solution-for-members-managing-weight-and-blood-glucose-with-or-without-glp-1-medications
New Research From Dario Demonstrates Abili...
03/12/2024 12:49:55

Study presented at ATTD 2024 is the first of a planned series examining the impact of Dario's integrated cardiometabolic so...

concurrent-to-twill-acquisition-deal-dariohealth-priced-224m-equity-financing
Concurrent To Twill Acquisition Deal, Dari...
02/21/2024 11:05:58

Dario priced a $22.4 million private placement of convertible preferred stock, priced at the market under Nasdaq rules, with pa...

dariohealth-has-acquired-twill-to-create-comprehensive-digital-offerings-for-chronic-conditions-dario-paid-10m-in-cash-and-agreed-to-issue-approximately-10m-shares-in-the-form-of-pre-funded-warrants
Dariohealth Has Acquired Twill, To Create ...
02/21/2024 11:04:15

Expecting nearly doubling Dario's pro forma revenues in 2023 Acquisition is immediately accretive to revenue and gross mar...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/12/2024 13:05:59

darios-cardiometabolic-announces-contract-to-provide-cardiometabolic-solutions-to-regional-union-financial-terms-not-disclosed
Dario's Cardiometabolic Announces Contract...
01/11/2024 13:33:20

Dario's integrated solution to support improved whole health gains traction in public and labor market

national-employer-selects-dario-cardiometabolic-and-glp-1-solutions-to-improve-employee-health
National Employer Selects Dario Cardiometa...
12/05/2023 13:40:54

New client will use Dario's integrated approach to support long-term behavior change for employees living with diabetes, pr...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
12/05/2023 13:07:35

dario-contracts-with-new-employer-for-cardiometabolic-solution-beginning-in-january-2024
Dario Contracts With New Employer For Card...
11/27/2023 13:38:49

Demand for Dario's integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 med...

dario-publishes-new-research-demonstrating-that-dario-users-that-increased-physical-activity-can-maintain-reduced-blood-glucose
Dario Publishes New Research Demonstrating...
11/13/2023 13:55:06

New study highlights the value of a whole health approach managing chronic conditions and supporting members using GLP-1sNEW YO...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
11/09/2023 21:31:10

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
11/03/2023 17:31:00

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION